Presentation
4 October 2022 Virtual immunohistochemical (IHC) staining of unlabeled tissue using deep learning (Conference Presentation)
Author Affiliations +
Abstract
Immunohistochemical (IHC) staining of the human epidermal growth factor receptor 2 (HER2) is routinely performed on breast cancer cases to guide immunotherapies and help predict the prognosis of breast tumors. We present a label-free virtual HER2 staining method enabled by deep learning as an alternative digital staining method. Our blinded, quantitative analysis based on three board-certified breast pathologists revealed that evaluating HER2 scores based on virtually-stained HER2 whole slide images (WSIs) is as accurate as standard IHC-stained WSIs. This virtual HER2 staining can be extended to other IHC biomarkers to significantly improve disease diagnostics and prognostics.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Bijie Bai, Hongda Wang, Yuzhu Li, Kevin De Haan, Francesco Colonnese, Yujie Wan, Jingyi Zuo, Ngan Doan, Xiaoran Zhang, Yijie Zhang, Jingxi Li, Wenjie Dong, Morgan A. Darrow, Elham Kamangar, Han Sung Lee, Yair Rivenson, and Aydogan Ozcan "Virtual immunohistochemical (IHC) staining of unlabeled tissue using deep learning (Conference Presentation)", Proc. SPIE PC12204, Emerging Topics in Artificial Intelligence (ETAI) 2022, PC122040O (4 October 2022); https://doi.org/10.1117/12.2632652
Advertisement
Advertisement
KEYWORDS
Tissues

Breast

Breast cancer

Diagnostics

Neural networks

Quantitative analysis

Receptors

Back to Top